Reimbursement Of Health Care By Health. Insurance For 2 2002

Original Language Title: úhrady zdravotní péče hrazené ze zdrav. pojištění pro 2 pol. 2002

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$20 per month, or Get a Day Pass for only USD$4.99.
251/2002 Sb.



DECREE



The Ministry of health



of 13 October. June 2002,



laying down the amount of reimbursement of health care covered by the public

health insurance, including regulatory restrictions for 2. half of 2002



The Ministry of health shall lay down pursuant to § 17 para. 11 (a). (b)) of the Act

No. 48/1997 Coll., on public health insurance and amending and supplementing

some related laws, as amended by Act No. 459/2000 Coll. (hereinafter referred to

"the Act"):



§ 1



This Decree lays down, in cases where it is not the result of the conciliation

management agreement pursuant to § 17 para. 8 of the Act,



and the amount of the reimbursement) of health care paid for by public health insurance

including regulatory restrictions for health care in health care

residential care, including specialised therapeutic institutes, hospitals

for long-term patients and medical device reporting treatment

day no. 00005 pursuant to Decree issuing the list of medical procedures

with the point values of ^ 1) (hereinafter referred to as "the list of performance"),



(b) the amount of the reimbursement) when providing emergency care in non-Contracting

health-care facilities.



§ 2



(1) health care provided in health establishments of the constitutional

care, with the exception of health care in specialised therapeutic institutes,

institutes for long-term patients and in medical devices

returning the treatment day no. 00005 according to the list of performances (hereinafter referred to as

"inpatient facilities"), shall be paid in accordance with the contractual arrangement between the medical

the insurance company and patient facilities



a) flat rate, or



(b)) according to the list of performances, or



c) at the request of post operative care facilities combined in an agreed manner of payment

with the payment for the diagnosis.



(2) price point for the payment of health care referred to in paragraph 1 (b). (b))

set for 1. half of 2001 remains in force for 2. half-year

2002. ^ 2)



(3) the amount of remuneration referred to in paragraph 1 (b). (c)) shall negotiate in the contract between

health insurance and, with the amount of fasility payment

the provision of acute care will be established to pay for diagnosis and

other health care will be covered by a flat rate.



(4) a different payment method than the one referred to in paragraph 1, it is possible, if

the total amount of the payment will be higher than the remuneration provided for in paragraph 1

(a). and) or (b)), inpatient facilities, and health insurance on a proposal from the

Socket device on such a method of payment agreed and this way

is not in conflict with the laws and regulations governing public health

insurance.



(5) If bed equipment and health insurance fund shall conclude an addendum to the

contract or agree a new contract containing new medical procedures

provided by fasility, or agree on a new structure

provided health care, health insurance company this fact into

the total amount of payments for 2. half of 2002 shall include, if that method is not

contrary to the laws and regulations governing public health insurance.



(6) the procedure for calculating the flat-rate amount and conditions for reimbursement under

paragraph 1 (b). a) and b) are set out in annex 1 to this notice.



(7) if payment of a flat rate referred to in paragraph 1 (b). and)

health insurance provides beyond the flat rate, and without application of the

other regulatory restrictions, if these are not referred to directly in the text

letters and)), 2. half of 2002, particularly the payment of



and kardiovertry and under) for cardiac pacemakers, including electrodes, provided

in the 2. half of 2002 in the case of reimplantací (performances no 55217 and 55219

included in the list of performances),



(b)) for the neuromodulační enhancers provided in 2. half of 2002 when

the treatment of epilepsy and Parkinson's disease,



(c)) for the neuromodulační enhancers and intrathekální pumps, provided by

treatment of chronic painful conditions, peripheral nerve stimulation

(PNS), stimulation of the spinal cord or the rear roots (SCS), deep brain

and korová stimulation, and for promoters of the front horns spinal (SARS) for

transversálních lesions of the dorsal given in 2. half of 2002 in bed

the establishments listed in Appendix 3 to this notice; inpatient facilities

referred to in annex 3 to this Ordinance may apply to the sum of the

health insurance in the Czech Republic up to 30 programmable

prostheses,



(d)) for the treatment of in vitro fertilization provided in 2. half of 2002

implementing standard treatment devices aboard the sterility method

fertilization, discontinued



e) medical procedures of hemodialysis No. 18051, 18052, 18510, 18513,

18521, 18522, 18530, 18550, 18560, 18570, and 18590 18580 by list

procedures provided in the 2. half of 2002, while the price point for the payment

These procedures set out for the 1. half of 2001 remains in force for 2.

half of 2002; ^ 3) for medical procedures # 18521, 18522, 18530, 18550,

18560, 18570, 18580 and 18590, referred to in the Decree, shall be fixed overhead

cost of 4 points per minute,



f) posted a particularly medicinal products for the treatment of hemophilia, referred to in

Annex No 4 to this Decree, granted 2. half of 2002 in bed

devices,



(g)) of a particularly charged to medicines for the treatment of HIV/AIDS,

antiretroviral medicines and medicines for comprehensive treatment

opportunistic infections, supplied in 2. half of 2002 in bed

the establishments listed in Appendix 5 to this Decree; antiretroviral

medicinal products and medicinal products for comprehensive treatment of opportunistic

infections are listed in Appendix 6 to this Ordinance,



(h)) to be particularly charged medicine Cerezyme, to treat disease

Morbus Gaucher, granted in the 2. half of 2002 only the children's clinic

adolescent medicine and General teaching hospital in Prague,



I) per treatment days resuscitation and intensive care no 00051 00052,,

00053, 00055, 00057, 00058, 00061, 00065, 00068 according to the list of performances

provided in the 2. half of 2002 when treating extensive burns, in

inpatient facilities referred to in annex 7 to this Decree, and

the price point for the payment of such performances fixed for 1. half-year 2001

remains valid for 2. half of 2002, ^ 4)



(j)) of a particularly charged medicines provided in the 2. half of 2002

in the treatment of cystic fibrosis in the bed of the establishments listed in the annex

# 8 to this Ordinance; the list of medicinal products is charged separately

listed in Appendix 9 to this Decree,



separately charged to) for medicinal products granted in 2. half of 2002 in

Cancer sick children treated with children's Oncology at the workplace

bed care establishments listed in annex 10 to this Decree; for a list of

separately charged to medicinal products is given in annex 11 to this

the Decree,



l) of a particularly charged balloon catheters and Stents in 2.

half of 2002 in connection with the implementation of direct percutaneous

transluminal angioplasty (PTCA) in acute myocardial infarction in

performance # 89435, 17117 89437 and included in the list of performance in bed

the establishments listed in Appendix 12 to this Decree,



m) for a particularly charged blockers destičkových glycoprotein

IIb/IIIa receptor (ATC group B01AC13 and B01AC16) listed in annex

# 19 of this Decree, granted 2. half of 2002 for the treatment of

acute myocardial infarction in the bed of the establishments listed in the annex

# 12 of this Decree,



n) for a particularly charged balloon catheters, stents, stent-grafty,

They embolizující, adhesive mixture, mikrokatetry and cerebrovascular

protective aids provided in the 2. half of 2002 when Endovascular

treatment (# 89323 performances, 89331 and 89423 listed in performance)

Arterial Aneurysms and dissection, stenosis cerebral arteries, brain

arteriovenous malformations, short circuits and devices referred to in

in annex 13 to this Decree,



about) a particularly charged material (24684 and code 71032) provided in the 2.

half of 2002 when the hernia operations using the methods of PHS (# 51517 and performances

51519 referred to in the list of performances),



p) a particularly charged material (67162 code) provided in the 2. half-year

2002 in the surgical treatment of stress urinary incontinence in women (no performance.

76601 referred to in the list of performance) in in-patient establishments referred to in

Appendix 14 to this Decree,



q) posted a particularly medicinal products (codes, 75379 90996, 93706 and

93707) provided in the 2. half of 2002 for the treatment of rabies in bed

devices,



r) posted a particularly medicinal products containing an active substance

erythropoietin listed in annex # 15 for the treatment of multiple myeloma and

Chronic Lymphocytic Leukaemia in 2. half of 2002 in

inpatient facilities referred to in annex 16 to this Decree,



separately charged with) for medicinal products containing an active substance

erythropoietin listed in annex # 15 for the treatment of tumors in germ

stage II-IV, ovarian cancer stage I-IIA, lung cancer,

breast cancer in I and II stage, cancer of the cervix in stage Ib, IIa,

IIB, cancers in the orofacial area, malignant tumors of the placenta

provided in the 2. half of 2002 in the bed of the establishments listed in the

Appendix 17 to this Decree,



t) a particularly charged material-splint, granted in the 2. half of 2002


in the performance of torakoplastika (# 57225 performance referred to in the list of performances),

conducted by the children's Clinic of surgery University Hospital Motol, Prague 5 and

University Hospital Brno-children's clinic, surgery, orthopedics and

traumatology. These devices can sum to health

insurance companies in the Czech Republic up to 15 individual plates in a solution

pectus excavatum,



u) for cochlear implant systems, provided by the sudden

two-sided deafness in adults, always only when well developed

speech; in children ohluchlých postlinguálně no less than half a year and in

kongenitálně deaf or ohluchlých prelinguálně, provided by the

not later than 6 years of age, in-bed teaching hospital facilities

Motol, Prague 5-ENT Clinic 1. the Faculty of medicine and ENT Clinic 2.

Faculty of Medicine (implants). These devices can sum

apply to health insurance in the Czech Republic up to 30

programmable cochlear implantation systems.



§ 3



(1) the health care provided by specialised therapeutic institutes is to be paid

under the contractual arrangement between the health insurance company, and to medical treatment

Institute



a) flat rate in annex No. 2), or



(b)) combined way according to annex 2 of part B)



(c) the performance manner according to the list).



(2) price point for the payment of health care referred to in paragraph 1 (b). (b))

set for 1. half of 2001 remains in force for 2. half-year

2002. ^ 5)



(3) the value of the overhead associated with the spot value of the respective treatment

days referred to in the list of performance increases compared to the overhead of the contracted

These treatment days in a 2. half of 2001 by 60 points, the resulting

the value of the Director shall not be more than a list of performances.



(4) the lump sum amount that is payable under section 17 of the medicinal products, para.

12 of the law, increases by $10 compared to 2. half of 2001.



(5) any other method of payment than those mentioned in paragraph 1, it is possible, if

the total amount of the payment will be higher than the remuneration provided for in paragraph 1

(a). and) or (b)), professional treatment and health insurance Institute for

design of vocational medical facility on this method of payment agreed and

This method is not in conflict with the law governing public

health insurance.



(6) If a specialist clinic and the health insurance fund shall conclude an addendum

to the Treaty, or to agree on a new Treaty, containing the new health

provided expert medical Institute, or negotiating a new

the structure provided by the health care, health insurance company, these

fact, to the total amount of payments for 2. half of 2002 shall include, if

This method is not in conflict with the law governing public

health insurance.



(7) the procedure for calculation and payment of the flat-rate combined way, above

and conditions for reimbursement referred to in paragraph 1 (b). a) and b) are set out in the annex

No 2 to this Decree.



§ 4



(1) health care provided in hospitals for long-term patients with

be paid in accordance with the contractual arrangement between the health insurance company and

medical facilities, according to a list provided by remuneration for performance

medical procedures.



(2) price point for the payment of health care referred to in paragraph 1 provided for the

1. half-year 2001 remains in force for 2. half of 2002. ^ 6)



(3) the value of the overhead associated with the spot value of the treatment of the day # 00024

indicated in the list of performance increases compared to the overhead of the contracted

the treatment of the day at 2. half of 2001 by 60 points, the resulting value

Director shall not be more than a list of performances.



(4) the lump sum amount that is payable under section 17 of the medicinal products, para.

12 of the Act, is increased by CZK 5 versus 2. half of 2001.



(5) any other method of payment than those mentioned in paragraph 1, it is possible, if

the total amount of the payment will be higher than the remuneration provided for in paragraph 1,

Sanatorium and health insurance company on the design of the hospital

for long-term patients on this method of payment agreed and this way

is not in conflict with the laws and regulations governing public health

insurance.



§ 5



(1) health care provided in health facilities

returning the treatment day no. 00005 referred to in the list of performances is to be paid

under the contractual arrangement between health insurance and health care

the device according to the list provided by the performance remuneration for medical procedures.



(2) price point for the payment of health care referred to in paragraph 1 provided for the

1. half-year 2001 remains in force for 2. half of 2002. ^ 7)



(3) the value of the agreed contract with overhead health insurance,

assigned to the point value of the treatment of the day no. 00005 referred to in

list of performances, increased by 60 points compared with 2. half of 2001, with

the resulting value of the overhead may not be higher than a list of performances.



(4) the lump sum amount that is payable under section 17 of the medicinal products, para.

12 of the Act, is increased by CZK 5 versus 2. half of 2001.



(5) any other method of payment than those mentioned in paragraph 1, it is possible, if

the total amount of the payment will be higher than the remuneration provided for in paragraph 1,

medical facilities and health insurance to the health care proposal

device on such a method of payment agreed and this method is not in the

contrary to the laws and regulations governing public health insurance.



§ 6



(1) the reimbursement of emergency health care, if there is no contract between the

medical facilities and health insurance must be carried out

provided by the medical procedures as follows:



and) dental out-patient care are reimbursed according to the rates applicable to

healthcare provided by dentists. half of 2002,



(b)) other health care are to be paid according to the list of performance and health

the undertaking may, on the basis of the law ^ 8) exercise regulatory restrictions by analogy

as for the contracting of medical facilities.



(2) price point for the payment of health care referred to in paragraph 1 (b). (b))

set for 1. half of 2001 remains in force for 2. half-year

2002. ^ 9)



§ 7



(1) if in the 2. half of 2002 will be the actual revenue from premium selection

After the redistribution is higher than the actual amount of the premium after the selection

redistribution in the 2. half of the year 2001, will increase the health insurance company

the medical establishment referred to in paragraph 1 (b). and the total amount of payment)

calculated in accordance with the procedure laid down in the annex to Decree No 18 to

This Decree.



(2) the revenue from the selection of premiums after the redistribution of data will be included

from the redistribution for the seventh to the twelfth month of the year 2002.



(3) the increase referred to in paragraph 1 shall be reimbursed by health insurance contract

medical institutions until 31 December 2006. in May 2003.



(4) if in the course of the 2. half of 2002 to change the list of services will be

These changes in the calculation of the increase referred to in paragraph 1 is taken into account.



(5) the health insurance fund by 30 June. April 2003 to provide medical

device data on actual revenue from a selection of premium total after

redistribution for the 2. half of 2002.



§ 8



This Decree shall enter into force on 1 January 2000. July 2002.



Minister:



Prof. MUDr. Fiser, CSc. v. r.



Č. 1



Procedure for calculating the flat-rate, amount and conditions for reimbursement pursuant to § 2 (2). 1

(a). a) and b)



And)



Payment of a flat rate



1. Reimbursement of health care provided by the bed devices includes:



and acute care reimbursement) reported on hospitalizačních accounts

including relevant performance complement (hereinafter referred to as "hospital

reimbursement "),



(b)) reimbursement of out-patient ambulatory care reporting on accounts, including

the relevant performance complement (hereinafter referred to as "ambulatory payment"),



(c) the payment of health transport performance) (hereinafter referred to as "traffic payment"),



(d) the payment of the other outputs) of health care, if the bed device

provides performance complement for other medical institutions, where appropriate,

other contracted performances (hereinafter referred to as "other remuneration").

If any of the listed types of inpatient health care facility

does not, then it is not part of the remuneration.



2. procedure for the determination of a flat rate for 2. half of 2002



The flat rate is calculated for each type of health care referred to in

1 (b). a) to (d)) of the amount of performance for the 2. half of 2001, which were

fasility reported and health insurance are recognised from 1.

July 2001 to 31 December 2002. in May 2002, where appropriate, of the volume of previous performance

periods that have been recognized by the health insurance company, but were not counted

the flat rate of previous periods, as follows:



The total volume of performances (especially the points charged to medicines and separately

posted material) is divided by the number of unique treated insured persons,

who have been in the bed device provided health care. Unique

treated by the insured person means one insured person regardless,

the number of times the device reported on this bed of the insured person in a specified

period of health care. Performances and unique treatment of the insured person is

be calculated separately for each type of payment in accordance with point 1 (b). a) to (d)).



The flat rate includes:



and the number of points per 1) unique treated the insured person,



(b)) a flat rate for a particularly charged medicines, especially posted

the material and plan for patients on 1 unique treated the insured person, in the

CZK.




2.1 the flat rate includes

sum sum BH ZH

PHB = -------- PHZ = --------

sum of the sum of the UH UH



where:



PHB = number of points an 1 unique treated the insured's 2. half-year

2001



BH = number of points for all of the medical procedures when

hospitalisation, including points for the category of patient by 2. half-year 2001

the post operative care facilities that were reported and fasility

health insurance company recognized by 1. July 2001 to 31 December 2002. May 2002,

In addition to the points:



and for medical procedures) paid for in 2. half of 2002 in excess of the flat-rate

the rates of inpatient or included in the other flat-rate,



(b)) for the declared and recognized by the medical procedures provided during hospitalization in

skills that are no longer for 2. half of 2002 contracted.



PHZ = flat rate for a particularly charged medicines, especially

posted material and for patients for a fixed fee provided in the 2 half-year 2001

hospitalized insured on 1 unique treated the insured person.



ZH = payment for medicines, particularly charged separately billed

material and for the lump sum provided in 2 patients. half-year 2001

hospitalized insured, who was banished and fasility

health insurance company recognized by 1. July 2001 to 31 December 2002. May 2002,

In addition to the separately posted material and separately charged to medicinal

products:



and paid in 2.) half of 2002 beyond the flat rate includes

or included in the other flat-rate,



(b)) provided during the hospitalization in skills that are no longer for

2. half of 2002 contracted.



UH = the number of unique treated insured persons, who have been in the 2. half-year

2001 hospitalized and their medical procedures have been provided by

the device reported and health insurance are recognised from 1. July 2001

until 31 December 2006. May 2002.



2.2 the flat rate for outpatient

sum sum for BA

PAB = ------- PAZ = -------

sum of the sum of UA UA



where:



PAB = dots per 1 unique treated the insured's 2. half-year

2001.



BA = number of points for all of the medical procedures in the out-patient clinics,

2. half of 2001 that were reported and fasility health

insurance recognised from 1. July 2001 to 31 December 2002. May 2002, in addition to the points:



and for medical procedures) paid for in 2. half of 2002 in excess of the flat-rate

rates of outpatient or included in the other flat-rate,



(b)) for the declared and recognized by the medical procedures provided in out-patient clinics in

skills that are no longer for 2. half of 2002 contracted.



PAZ = flat rate for a particularly charged medicines and separately

posted material provided in the 2. half of 2001 in the out-patient clinics treated

insurance policy holders on 1 unique treated the insured person.



A = remuneration for the separately charged medicines and separately billed

material provided in the 2. half of 2001 in the out-patient clinics treated

the insured, who was banished and fasility health

the insurance company accepted from 1. July 2001 to 31 December 2002. May 2002, in addition to separately

the posted material and separately charged of medicinal products:



and paid in 2.) half of 2002 beyond the flat rate for outpatient

or included in the other flat-rate,



(b)) provided in the out-patient clinics in the specializations that are no longer for 2.

half of 2002 contracted.



UA = the number of unique treated insured persons, who have been in the 2. half-year

2001 in out-patient clinics treated and they provided medical procedures that

were reported and fasility health insurance recognised from 1.

July 2001 to 31 December 2002. May 2002.



2.3. A flat rate per medical transport

sum sum BD ZD

PDB = -------- PDZ = -------

sum sum UD UD



where:



PDB = dots per 1 unique treated the insured's 2. half-year

2001



BD = number of points for all of the medical procedures in health

transport in the 2. half of 2001 of post operative care facilities that were

fasility reported and health insurance are recognised from 1.

July 2001 to 31 December 2002. May 2002, in addition to the points:



and for medical procedures) paid for in 2. half of 2002 in excess of the flat-rate

rates for medical transport or included in the other flat-rate,



(b)) for the declared and recognized by the medical procedures provided in health

transport, that are no longer for 2. half of 2002 contracted.



PDZ = flat rate for a particularly charged medicines and separately

posted material provided in the 2. half of 2001 in the medical transport

transported or treated the insured on 1 unique treated

of the insured person.



ZD = payment for separately charged medicines and separately billed

material provided in the 2. half of 2001 in the medical transport

transported or treated the insured, who was patient

the device recorded and recognised health insurance from 1. July 2001 to

May 31, 2002, in addition to the separately posted material and separately charged

medicinal products:



and paid in 2.) half of 2002 beyond the flat rate for health

transport or included in the other flat-rate,



(b)) was provided when the performances in the medical transport, that are no longer for

2. half of 2002 contracted.



UD = the number of unique treated insured persons, who have been in the 2. half-year

2001 in the medical transport transported or treated and jim

medical procedures were reported and fasility

health insurance company recognized by 1. July 2001 to 31 December 2002. May 2002.



2.4 the flat rate for other medical procedures

sum sum REV. BJ

PJB = -------- PJZ = --------

sum sum UJ UJ



where:



PJB = dots per 1 unique treated the insured's 2. half-year

2001



BJ = number of points for all other medical procedures provided in the 2.

half of 2001 of post operative care facilities that were fasility

reported and health insurance are recognised from 1. July 2001 to 31 December 2002.

May 2002, in addition to the points:



and for medical procedures) paid for in 2. half of 2002 in excess of the flat-rate

the rates for other medical procedures or included in the other flat-rate,



(b)) in the reported and recognized by other medical procedures provided in

skills that are no longer for 2. half of 2002 contracted.



PJZ = flat rate for a particularly charged medicines and separately

posted material provided in the 2. half of 2001 when other health

performance treated insureds 1 unique treated the insured person.



ZJ = payment for separately charged medicines and separately billed

material provided in the 2. half of 2001 when other medical procedures

treated the insured, who was banished and fasility health

the insurance company accepted from 1. July 2001 to 31 December 2002. May 2002, in addition to separately

the posted material and separately charged of medicinal products:



and paid in 2.) half of 2002 beyond the flat rate for other

medical procedures or included in the other flat-rate,



(b)) was provided when other medical procedures in the fields of medicine, which

are no longer for 2. half of 2002 contracted.



UJ = the number of unique treated policyholders who were at 2. half-year

2001 receiving other medical procedures that were fasility

reported and health insurance are recognised from 1. July 2001 to 31 December 2002.

May 2002.



3. The calculation of the lump-sum payment of 1 point



When calculating the amount of the flat-rate payment for 1 point is based on the individual

the amount of the remuneration for the 1 point in 2. half of 2001, which modifies the

a differentiated increase of payment in 3 zones (described in section 3.2).



3.1 an individual amount of remuneration for the 1 point (IVUB) 2. half-year 2001

represents the proportion of the total remuneration without separately charged to medicinal

products and separately charged material on 1 point. Shall be determined in accordance with

the following formula: sum of PAYMENT of 2. Col. 2 of 2001. pol. 2001 IVUB 2.

mid 2001 =------------------------------------------a sum of POINTS 2.

mid-2001



where:



PAYMENT of 2. mid-2001 = remuneration for all medical procedures,

including categories of patient, provided by fasility in 2.

half of 2001 that were reported and recognised from 1. July 2001 to 31 December 2002.

May 2002; This payment will not count towards medical procedures that

are in 1. half of 2002 paid in excess of the flat-rate.



From the 2. mid-2001 = payment for separately charged medicines and separately

the posted material, provided in a 2. half of 2001, which was a single

the device recorded and recognised health insurance from 1. July 2001 to

May 31, 2002; This remuneration shall not be charged separately charged

medicines and separately posted material that is in the 2. half-year

2002 paid in excess of the flat-rate.



POINTS 2. mid-2001 = the number of medical procedures and for the categories

the patient provided by fasility in 2. half of 2001, which

were reported and fasility health insurance recognised from 1.

July 2001 to 31 December 2002. May 2002; These points do not count towards the points

for medical procedures, which are in the 2. half of 2002 paid in excess of the

the flat rate.



3.2 the lump-sum payment for 1 point (PUB) for 2. half of 2002 is based on the


individual amount of remuneration for 1 point, detected in 2. half of 2001.



Shall be determined as follows:



If the calculated IVUB) is less than $, 0.89 PUB for 2.

half of 2002 amounts to $, 0.89



(b)) if the calculated IVUB is equal to 0.89 Eur or less than or equal to 0.99

CZK, added to this IVUB 0.01 € (PUB = IVUB + 0.01)



(c)) if the calculated IVUB is equal to or higher than CZK 1, the

computed IVUB (PUB = IVUB).



4. the calculation of the total payment for the health care



4.1 the flat-rate remuneration for each type of health care referred to in section 1

(a). and) to d) on 1 unique treated the insured person is made up of

by multiplying the number of dots per 1 unique flat-rate insured person treated

remuneration for 1 point (PUB) and by adding the volume of flat rate, particularly

posted medicines and separately charged materials paid for 1

unique treated the insured person.



The calculation of the lump-sum payment on 1 unique treated the insured's

different types of health care referred to in point 1 (b). a) to (d)) for 2.

half of 2002 is as follows:



PHU = (PHB x PUB) + PHZ



PAU = (PAB x PUB) + PAZ



PDU = (PDB x PUB) + PDZ



PJU = (PJD x PUB) + PJZ



where:



PHU = lump sum payment on 1 unique inpatient treated

of the insured person



PAU = lump sum payment per 1 outpatient unique treated the insured person



PDU = flat-rate remuneration of transport on 1 unique treated the insured person



PJU = lump sum payment to 1 other unique treated the insured person



4.2 remuneration for each type of health care referred to in point 1 (b). a) to

(d)) shall be calculated so that the flat-rate payment on 1 unique treated

the insured person shall be multiplied by the number of unique treated policyholders in

the reporting period,



as follows:



Hu = PHC x UHV



Au = PAC x UAV



DU = PDC x UDV



JU = PJC x UJV



where:



Hu = inpatient reimbursement



Au = outpatient reimbursement



DU = transportation reimbursement



JU = other charge



UHV = the number of inpatients treated policyholders facing unique

health care was reported in 2. half of 2002 and recognized

health insurance company



UAV = the number of unique treated policyholders who were ambulatory

health care, reported in 2. half of 2002 and recognized

health insurance company



UDV = the number of unique treated policyholders who have been health

to the right is granted, reported in 2. half of 2002 and recognized by health

the insurance company



UJV = the number of unique treated policyholders who were other performances

provided, shown in the 2. half of 2002 and recognized by the health insurance company



4.3 the total remuneration (CU) is the sum of the individual types of payments:



CU = HU + AU + DU + JU



Part of the total remuneration are on payment procedures under section 2 (2). 5 of this

the Decree.



5. Calculation of the remuneration in the regulation of prescription medicinal products, and

medical devices



In the calculation of the total health care payments according to section 4.3 is on

apply regulatory mechanisms that are based on a comparison of average

payment for prescribed medicines and medical devices to 1

treated the insured person between 2. half of 2001 and 2. half of 2002. From

the comparison excludes medicinal products and medical devices

the review of the approved doctor or paid in excess of the flat-rate basis in accordance with

§ 2 (2). 7.



5.1 in the event that the average payment for prescribed medicines and

medical devices to 1 client in treated 2. half of 2002

exceeds 104% of the average of the reference remuneration, which is made up of remuneration for

prescribed medicines and medical devices to 1 treated

of the insured person in the 2. half of the year 2001, it will be established the reduction of 60% of the

the total exceeded that is calculated as the product of the number of treated

insured persons in a given period and the amount of the cost overrun on medicinal products

and medical devices to 1 compared to 104% of the treated the insured person

the average of the reference remuneration for medicinal products and medical

resources on 1 treated the insured person



5.2 If the average payment for prescribed medicines and medical

resources on 1 of the insured person in a treated 2. half of 2002 it reaches 100

% of the average of the reference remuneration, which is made up of remuneration for prescribed

medicines and medical devices to 1 treated the insured person in

2. half-year 2001, the payment for 2. half of 2002 increased by 40%

the achieved savings. This saving is calculated as the product of the number of treated

insured persons in a given period and the level of under-execution of the cost of medicines

medicines and medical devices to 1 the insured person as opposed to treated

100% of the average of the reference remuneration for medicinal products and medical

resources on 1 treated the insured person.



6. the provision of monthly backup



Health insurance company will provide lůžkovému equipment monthly deposit of

107% of one-sixth of the volume of payment that have been this lůžkovému device

paid 2. half of 2001. If the amount of the advance was so calculated

less than 108% of the volume of payments that were paid for devices lůžkovému

2. half of the year 2000, will provide health insurance medical facility

monthly deposit of 108% of one sixth of the volume of payments for 2. half-year

2000.



(B))



Payment according to performance list



1. Way of payment pursuant to § 2 (2). 1 (b). (b)) can only be redeemed at the

-bed facility where the provided volume significantly fluctuating health

care paid for by public health insurance, where it is not possible to determine the

flat rate over the reference period because of the small number of treated

the health insurance companies and the insured where inpatient facilities in

average of one health insurance company shall not charge more than 300 000 CZK

calendar quarter.



2. If the Contracting Parties agree, this variant can also select in the

the case of higher volume of the Bill, however, must be met

dramatically fluctuating volume of provided health care.



3. the health care provided by the medical establishment has significantly

variable volume if the volume of reported health care for

each month in 2. half of 2001 were different in at least one case, the

more than 25%.



Č. 2



Procedure for calculating the flat-rate remuneration and combined way, above and

conditions for reimbursement pursuant to § 3 (2). 1 (b). a) and b)



And)



Payment of a flat rate



The remuneration amounts to 107% of the comparison of the volume of payments. Matching the volume of payment

is equal to the payment for health care provided in the corresponding 2.

half of 2001, area declared and recognised from 1. July 2001 to 31 December 2002. may

2002, and the comparison of the volume does not include remuneration for the

provided health care in the comparative period in cases where the

care is no longer in the professional treatment of the Institute is provided, or is paid

otherwise.



1. conditions of payment



Remuneration of 107% belongs only on the condition that the reported number of

2 days of treatment. half of 2002 is at least 95% of the number of

reported on 2 days of treatment. half of 2001. In the case that professional

Clinic reports less than 95% of these set of treatment days,

will be provided for the total rate for 2. half of 2002 under the bed

care has been reduced by a percentage which was not filled with the limit of the number of

treatment days.



2. the calculation of the remuneration in the regulation of prescription medicinal products, and

medical devices



Regulatory mechanisms are based on a comparison of the average remuneration for

prescribed medicines and medical devices to 1 treated

of the insured person between 2. half of 2001 and 2. half of 2002. A comparison of the

exclude medicinal products and medical devices approved by the review

doctor.



2.1. In the case that the average payment for prescribed medicines and

medical devices to 1 client in treated 2. half of 2002

exceeds 104% of the average of the reference remuneration, which is made up of remuneration for

prescribed medicines and medical devices to 1 treated

of the insured person in the 2. half of the year 2001, it will be established the reduction of 60% of the

the total exceeded that is calculated as the product of the number of treated

insured persons in a given period and the amount of the cost overrun on medicinal products

and medical devices to 1 compared to 104% of the treated the insured person

the average of the reference remuneration for medicinal products and medical

resources on 1 treated the insured person.



2.2 If the average payment for prescribed medicines, medical

resources on 1 of the insured person in a treated 2. half of 2002 it reaches 100

% of the average of the reference remuneration, which is made up of remuneration for prescribed

medicines and medical devices to 1 treated the insured person in

2. half-year 2001, the payment for 2. half of 2002 increased by 40%

the achieved savings. This saving is calculated as the product of the number of treated

insured persons in a given period and the level of under-execution of the cost of medicines

medicines and medical devices to 1 the insured person as opposed to treated

100% of the average of the reference remuneration for medicinal products and medical

resources on 1 treated the insured person.



(B))



Payment of combined way




A combined method of payment will be used for specialized therapeutic institutes, which

inpatient care have only contracted medical procedures of treatment

day, or performances, which show the receipt and discharge

examination of the list of performances.



1. Reimbursement of inpatient care



Inpatient care will be covered by the payment per treatment day and for performances,

which show the receipt and discharge examination referred to in the list

performances with the price point according to § 3 (2). 2 of this order.



2. Reimbursement of out-patient care, medical transportation and other health

performance



Out-patient care, medical transportation and other medical procedures will be

covered by a flat rate, which is calculated from the volume of outputs for 2. half-year

2001, which were professional therapeutic Institute reported and health

insurance recognised from 1. July 2001 to 31 December 2002. in May 2002, where appropriate, of

the volume of the performance of previous periods that have been health insurance

recognized, but not included in the flat rate of previous periods,

as follows:



The total volume of medical procedures (points and separately charged to healing

preparations and posted material) is divided by the number of unique

insured persons who have been treated in the specialized treatment institution provided

health care. Unique treated the insured person means one

the insured person, regardless of how many times a specialist clinic has reported on

of the insured person within a specified time period of health care. Performances and

a unique treatment of insured persons shall be calculated separately for outpatient care,

medical transport and other medical procedures.



The flat rate includes:



and the number of points per 1) unique treated the insured person,



(b)) a flat rate for a particularly charged medicines, especially posted

material and fee for patients treated in the insured person's unique 1.



2.1 flat rate for outpatient

sum sum for BA

PAB = -------- PAZ = --------

sum of the sum of UA UA



where:



PAB = dots per 1 unique treated the insured's 2. half-year

2001



BA = number of points for all of the medical procedures in the out-patient clinics in

2. half of the year 2001 of vocational medical facility reported

and recognised from 1. July 2001 to 31 December 2002. May 2002, in addition to the points:



and for medical procedures) paid for in 2. half of 2002 in excess of the flat-rate

rates of outpatient or included in the other flat-rate,



(b)) for the declared and recognized by the medical procedures provided in out-patient clinics in

skills that are no longer for 2. half of 2002 contracted.



PAZ = flat rate for a particularly charged medicines and separately

posted material provided in the 2. half of 2001 in the out-patient clinics treated

insurance policy holders on 1 unique treated the insured person.



A = remuneration for the separately charged medicines and separately billed

material provided in the 2. half of 2001 in the out-patient clinics treated

the insured, who was banished and recognised from 1. July 2001 to 31 December 2002.

May 2002.0, in addition to the separately posted material and separately charged

medicinal products:



and paid in 2.) half of 2002 beyond the flat rate for outpatient

or included in the other flat-rate,



(b)) provided in the out-patient clinics in the specializations that are no longer for 2.

half of 2002 contracted.



UA = the number of unique treated insured persons, who have been in the 2. half-year

2001 in out-patient clinics with medical procedures have been reported and recognized

from the 1. July 2001 to 31 December 2002. May 2002.0.



2.2 the flat rate for medical transport

sum sum BD ZD

PDB = ------- PDZ = -------

sum sum UD UD



where:



PDB = dots per 1 unique treated the insured's 2. half-year

2001



BD = number of points for all of the medical procedures in health

transport in the 2. half of 2001 of vocational medical facility that

were reported and recognised from 1. July 2001 to 31 December 2002. May 2002.0, in addition to

points:



and for medical procedures) paid for in 2. half of 2002 in excess of the flat-rate

rates for medical transport or included in the other flat-rate,



(b)) for the declared and recognized by the medical procedures provided in health

transport, that are no longer for 2. half of 2002 contracted.



PDZ = flat rate for a particularly charged medicines and separately

posted material provided in the 2. half of 2001 in the medical transport

transported or treated the insured on 1 unique treated

of the insured person.



ZD = payment for separately charged medicines and separately billed

material provided in the 2. half of 2001 in the medical transport

transported or treated the insured, who was banished and recognized

from the 1. July 2001 to 31 December 2002. May 2002, in addition to the separately posted

material and separately charged of medicinal products:



and paid in 2.) half of 2002 beyond the flat rate for health

transport or included in the other flat-rate,



(b)) was provided when the performances in the medical transport, that are no longer for

2. half of 2002 contracted.



UD = the number of unique treated insured persons, who have been in the 2. half-year

2001 in the medical transport transported or treated and health

the performances were recorded and recognised from 1. July 2001 to 31 December 2002. May 2002.



2.3 the flat rate for other medical procedures

sum sum REV. BJ

PJB = ------- PJZ = -------

sum sum UJ UJ



where:



PJB = dots per 1 unique treated the insured's 2. half-year

2001



BJ = number of points for all other medical procedures provided in the 2.

half of 2001 of vocational medical facility, that have been reported and

recognised from 1. July 2001 to 31 December 2002. May 2002, in addition to the points:



and for medical procedures) paid for in 2. half of 2002 in excess of the flat-rate

the rates for other medical procedures or included in the other flat-rate,



(b)) in the reported and recognized by other medical procedures provided in

skills that are no longer for 2. half of 2002 contracted.



PJZ = flat rate for a particularly charged medicines and separately

posted material provided in the 2. half of 2001 when other health

performance treated insureds 1 unique treated the insured person.



ZJ = payment for separately charged medicines and separately billed

material provided in the 2. half of 2001 when other medical procedures

treated the insured, who was banished and recognised from 1. July 2001 to

May 31, 2002.0, in addition to the separately posted material and separately charged

medicinal products:



and paid in 2.) half of 2002 beyond the flat rate for other

medical procedures or included in the other flat-rate,



(b)) was provided when other medical procedures in the fields of medicine, which

are no longer for 2. half of 2002 contracted.



UJ = the number of unique treated policyholders who were at 2. half-year

2001 receiving other medical procedures that have been declared and recognised by

1 July 2001 to 31 December 2002. May 2002.



3. Calculation of the remuneration for the health care



3.1 the lump-sum payment for out-patient care, health services and other

medical procedures on 1 unique treated the insured person is made up of

by multiplying the number of dots per 1 unique flat-rate insured person treated

remuneration for 1 point and by adding the volume of flat rate for a particularly charged

medicines and separately charged materials paid on 1 unique

treated the insured person.



The calculation of the lump-sum payment on 1 unique treated the insured's

the different types of health care for 2. half of 2002 is as follows:



PAU = (PAB x CB) + PAZ



PDU = (PDB x CB) + PDZ



PJU = (PJB x CB) + PJZ



where:



PAU = lump sum payment per 1 outpatient unique treated the insured person



PDU = flat-rate remuneration of transport on 1 unique treated the insured person



PJU = lump sum payment to 1 other unique treated the insured person



CB = price point according to § 3 (2). 2 of this order



3.2 payment for out-patient care, health services and other health

performance is calculated so that the flat-rate payment shall be multiplied by the number of

unique treated insured persons during the reporting period,



as follows:



Au = PAU x UAV



DU = PDU x UDV



JU = PJU x UJV



where:



Au = outpatient reimbursement



DU = transportation reimbursement



JU = other charge



UAV = the number of unique treated policyholders who were ambulatory

health care, reported in 2. half of 2002 and recognized

health insurance company



UDV = the number of unique treated policyholders who have been health

to the right is granted, reported in 2. half of 2002 and recognized by health

the insurance company



UJV = the number of unique treated insured persons, to whom the other performances

provided, shown in the 2. half of 2002 and recognized by the health insurance company



3.3 total remuneration (CU) is the sum of the individual types of payments:



CU = AU + DU + JU



Part of the total remuneration are further payment procedures pursuant to § 3 (2). 6 of this

the Decree.



4. the calculation of the remuneration in the regulation of prescription medicinal products, and

medical devices



In the calculation of the total health care payments according to section 3.3 shall be further

apply regulatory mechanisms that are based on a comparison of average

payment for prescribed medicines and medical devices to 1


treated the insured person between 2. half of 2001 and 2. half of 2002. From

the comparison excludes medicinal products and medical devices

revision approved by the doctor.



4.1 in the event that the average payment for prescribed medicines and

medical devices to 1 client in treated 2. half of 2002

exceeds 104% of the average of the reference remuneration, which is made up of remuneration for

prescribed medicines and medical devices to 1 treated

of the insured person in the 2. half of the year 2001, it will be established the reduction of 60% of the

the total exceeded that is calculated as the product of the number of treated

insured persons in a given period and the amount of the cost overrun on medicinal products

and medical devices to 1 compared to 104% of the treated the insured person

the average of the reference remuneration for medicinal products and medical

resources on 1 treated the insured person.



4.2 If the average payment for prescribed medicines, medical

resources on 1 of the insured person in a treated 2. half of 2002 it reaches 100

% of the average of the reference remuneration, which is made up of remuneration for prescribed

medicines and medical devices to 1 treated the insured person in

2. half of the year 2001 will be the payment for 2. half of 2002 increased by 40%

the achieved savings. This saving is calculated as the product of the number of treated

insured persons in a given period and cost medicines's and

medical devices to 1 100% treated compared to the insured person

the average of the reference remuneration for medicinal products and medical

resources on 1 treated the insured person.



Č. 3



List of in-patient-center for the treatment of chronic pain

States

------------------------------------------------------------------

no name of the socket device ID the registered office

------------------------------------------------------------------

1.00023884 Na Homolce hospital Prague 5

2.00064203 teaching hospital in motol Prague 5

3.61383082 central military hospital Prague Prague 6

4.00159816 of the University Hospital. Anny In Brno

5.65269705 the Faculty hospital Brno, Brno

6.00098892 University Hospital Olomouc, Olomouc 5

------------------------------------------------------------------



Č. 4



List separately charged medicinal products for the treatment of hemophilia

------------------------------------------------------------------------

ATC code Name the add-in name

------------------------------------------------------------------------

PROTHROMPLEX TOTAL TIM 86657 B02BD01 4 200I. E INJ SIC 1X200UT + SOL

PROTHROMPLEX TOTAL TIM B02BD01 75634 4 600I. E INJ SIC 1X600UT + SOL



B02BD02 53360 ANTIHEM. F. (HUMAN), SIC HEMOFIL M INJ 1X1000UT + SAT

93006 B02BD02 ANTIHEM. F. (HUMAN), SIC HEMOFIL M INJ 1X250UT + SOL

53359 B02BD02 ANTIHEM. F. (HUMAN), SIC HEMOFIL M INJ 1X500UT + SOL

87240 B02BD02 FANHDI 1000 IU INJECTION, SIC 1X1KU + SOLV.

87238 B02BD02 FANHDI 250 IU INJECTION, SIC 1X250UT + SOL

87239 B02BD02 FANHDI 500 IU INJECTION, SIC 1X500UT + SOL

B02BD02 60381 HAEMOCTIN SDH 1000 INJ SIC 1X1KU + SOLV.

B02BD02 60379 HAEMOCTIN SDH 250 INJ SIC 1X250UT + SOL

B02BD02 60380 HAEMOCTIN SDH INJ 500 SIC 1X500UT + SOL

89029 B02BD02 IMMUNATE STIM PLUS 1000 INJ SIC 1X1KU + SOLV.

89027 B02BD02 IMMUNATE STIM PLUS 250 INJ SIC 1X250UT + SOL

89028 B02BD02 IMMUNATE STIM PLUS 500 INJ SIC 1X500UT + SOL

B02BD02 58700 OCTANATE 1000 INJ SIC 1X1000UT + SOL

B02BD02 58278 OCTANATE 250 I.U. INJ SIC 1 x 250 UT + SOL

B02BD02 58279 OCTANATE 500 I.U. INJ 1 x 500 UT SIC + SOL

B02BD02 10747 REFACTO 1000 I.E. INJ LQF PSO 1X1KU

B02BD02 10745 REFACTO 250 I.E. INJ LQF PSO 1X250UT

10746 REFACTO B02BD02 500 I.E. INJ LQF PSO 1X500UT



FEIBA TIM 4 1000 85677 B02BD03 J. INJ SIC 1X1KU + SOLV.

85676 B02BD03 FEIBA TIM 4 500 J. INJ SIC 1X500UT + SOL

B02BD04 75080 IMMUNINE 1200 E. INJ SIC 1.2 KU + 10 ml

B02BD04 75079 IMMUNINE 600 I.E. INJ SIC 1X600UT + 5 ml

B02BD04 OCTANINE F 1000 57481 INJ LQF PSO 1X1KU

B02BD04 OCTANINE F 250 57468 INJ LQF PSO 1X250UT

B02BD04 OCTANINE F 500 57477 INJ LQF PSO 1X500UT



B02bd08 89826 NOVOSEVEN 120 KIU (1.5 MG) INJ SIC 1 x 2.4 MG + SOL

B02bd08 58496 NOVOSEVEN 120KIU (1.5 MG) INJ SIC 2.4 MG + SAT + PAGE

B02bd08 92641 NOVOSEVEN 240KIU (3.0 MG) INJ SIC 1 x 4.8 MG + SOL

B02bd08 58497 NOVOSEVEN 240KIU (3.0 MG) INJ SIC 4.8 MG + SAT + PAGE

B02bd08 58495 NOVOSEVEN 60KIU (1.2 MG) INJ SIC 1.2 MG + SAT + PAGE

B02bd08 89825 NOVOSEVEN 60KIU (1.2 MG) INJ SIC 1 1.2 MG + SOL

------------------------------------------------------------------------



Č. 5



A list of selected device-bed center for the treatment of HIV/AIDS

+--+----------+-------------------------+-----------+---------------------+

| # | CORPORATE ID | The name of the post operative care | Head Office | The workplace |

| | | equipment | | |

+--+----------+-------------------------+-----------+---------------------+

| # 1 | 65269705 | University Hospital Brno | Brno-main clinic |

| | | | Bohunice | infectious diseases |

+--+----------+-------------------------+-----------+---------------------+

| 2 | 00179906 | University Hospital | Hradec | infectious |

| | | | Kings | clinic |

+--+----------+-------------------------+-----------+---------------------+

| # 3 | 00843989 | University Hospital | Ostrava-| clinic |

| | | with health center | Poruba | treatment |

| | | | infectious and AIDS | |

+--+----------+-------------------------+-----------+---------------------+

| 4 | 00669806 | University Hospital | Pilsen | AIDS Center |

| | | | |-infectious clinics |

+--+----------+-------------------------+-----------+---------------------+

| 5. | 00064211 | University Hospital | Prague 8 | AIDS Center |

| | | The NA bulovce hospital | |-infectious clinics |

+--+----------+-------------------------+-----------+---------------------+

| 6 | 00673544 | Masaryk hospital | Usti nad | Department |

| | | with health center | Labem | communicable diseases |

+--+----------+-------------------------+-----------+---------------------+

| 7 | 00072711 | Hospital infectious Czech Czech | | |

| | | Budějovice | Budějovice | hospital |

+--+----------+-------------------------+-----------+---------------------+



Č. 6



Antiretroviral medicines and medicines for comprehensive treatment

opportunistic infections in HIV/AIDS

-------------------------------------------------------------------------

ATC code Name the add-in name

-------------------------------------------------------------------------

J01CA12 PIPRIL 2GM 94251 INJ SIC 1X2GM

J01CA12 PIPRIL 4GM INF 58182 SIC 1X4GM

J01CA12 PIPRIL 4GM 94252 INJ SIC 1X4GM

J01CR02 72972 ANTIBIOTICS 1.2 GM INJ SIC 5 x 1.2 GM

J01CR02 05951 ANTIBIOTICS 1 g TBL OBD 14X1GM

J01CR02 ANTIBIOTICS for 375 mg TBL 85524 OBD 21X375MG

J01CR02 72973 5X600MG 600 mg INJECTION, ANTIBIOTICS for SIC

J01CR02 97660 AUGMENTIN 1.2 G INJ SIC 5 x 1.2 GM

J01CR02 66020 AUGMENTIN 1.2 GM INJ SIC 10 x 1.2 GM

J01CR02 92207 AUGMENTIN 1.2 GM INJ SIC 5 x 1.2 GM

J01CR02 600 mg AUGMENTIN 92206 INJ SIC 10X600MG

J01CR02 CURAM 53577 625MG TBL OBD 21X625MG



J01CR03 93169 TIMENTIN 1.6 GM INJ SIC 4 x 1.6 GM

J01CR03 93170 TIMENTIN 3.2 GM INJ SIC 4 x 3.2 GM



J01CR05 TAZOCIN 2.25 GM 84783 INJ SIC 1 x 2.25 GM

J01CR05 TAZOCIN 4.5 GM 84784 INJ SIC 1 x 3.5 GM



J01DA 94756 2GM SULPERAZON IM/IV INJ SIC 1 (1GM + 1GM)



J01DA10 CEFOTAXIME 94176 LEK 1GM INJ SIC 1X1GM

J01DA10 93715 CLAFORAN INJ 1X1GM

J01DA10 11354 CLAFORAN 1.0 G I.V., I.M. INJ SIC 1X1GM

J01DA10 SEFOTAK 53235 0.5 GM INJ SIC 1 x 0.5 GM + SOL

J01DA10 SEFOTAK 1GM 53236 INJ SIC 1X1GM + SOLV.

J01DA10 SIC 1X1GM TAXCEF INJ 05770

05768 J01DA10 TAXCEF INJ SIC 1X500MG

J01DA10 TAXCEF 2 g 05748 INJ SIC 1X2GM



J01DA11 76353 1 g INJ SIC 1X1GM FORTUM

J01DA11 76354 FORTUM 2 g INJ SIC 1X2GM

J01DA11 76355 FORTUM 500 mg INJECTION, SIC 1X500MG



J01DA13 01645 CEFTRIAXONE 1000-SL INJ SIC 5X1GM

J01DA13 01649 CEFTRIAXONE 2000-SL INF SIC 1X2GM

J01DA13 01648 CEFTRIAXONE 2000-SL INJ SIC 5X2GM

01647 J01DA13 CEFTRIAXONE 500-SL INJ SIC 5 x 0.5 GM

J01DA13 LENDACIN 1 g INJ 80662 SIC 5X1GM

J01DA13 NOVOSEF 1 g Im 54086 INJ SIC 1X1GM + SOLV.

J01DA13 NOVOSEF 1 g I.V. 54085 INJ SIC 1X1GM + SOLV.



J01DA23 76233 SUPRAX TBL OBD 10X200MG



87199 J01DA24 MAXIPIME 1 GM INJ SIC 1X1GM

87200 J01DA24 MAXIPIME 2 GM INJ SIC 1X2GM

87198 J01DA24 SIC 1X500MG MAXIPIME INJ 500 mg

J01DA32 75039 CEFOBID 1 GM INJ SIC 1X1GM



86699 J01DA37 CEFROM 1GM INJ SIC 1X1GM



86412 J01DF01 AZACTAM 1 G INJ SIC 1X1GM



J01DH02 83417 MERONEM INJ SIC 10X1GM

J01DH02 83487 MERONEM INJ SIC 10X500MG



J01ee01 11706 BISEPTOL 480 INJ 10X5ML

J01ee01 75023 COTRIMOXAZOL AL FORTE TBL 20X960MG

J01ee01 PRIMOTREN 91281 INJ 10X5ML



J01FF01 98212 DALACIN C INJECTION 3X6ML/900MG

J01FF01 DALACIN C 91193 150 CPS 100X150MG

J01FF01 97878 KLIMICIN INJ 10X2ML/300 mg

J01FF01 64630 KLIMICIN INJ 10X4ML/600 mg



J01FF02 01835 1X2ML/600 mg LINCOCIN INJECTION


J01FF02 NELOREN 91997 CPS 16X500MG

J01FF02 97565 NELOREN INJ 10X2ML/600 mg



J01GB03 96413 GENTAMICIN LEK 40 mg/2 ml INJ 10X2ML/40 mg

J01GB03 96414 GENTAMICIN 80 mg/2 ml LEK INJ 10X2ML/80 mg



J01GB06 11785 AMIKIN INJECTION 1 G 1X4ML/1GM

AMIKIN INJECTION 100 mg 03951 J01GB06 1X2ML/100 mg

AMIKIN INJECTION 500 mg J01GB06 03952 1X2ML/500 mg



90485 J01GB07 NETROMYCINE 200 mg/2 ml 1X2ML/INJ 200 mg

83736 J01GB07 NETROMYCINE 400 mg/2 ml INJECTION 1X2ML/400 mg



J01MA01 OFLOXIN INF INF 66137 1X100ML/200 mg

92740 TARIVID Iv 200 J01MA01 INF 5X100ML/200 mg

J01MA01 ZANOCIN 200 mg TBL 12349 OBD 10X200MG



J01MA02 53715 CIFLOXINAL TBL OBD 200X250MG

J01MA02 CIPHIN for INFUSION 53922.200 mg/100 ml 1X100ML INF/200 mg

53921 J01MA02 CIPHIN 100 mg/50 ml for INFUSIONE INF 1X50ML/100 mg

J01MA02 56830 CIPLOX INF 1X100ML (plastic)

J01MA02 44986 CIPLOX 500 TBL OBD 50X500MG

J01MA02 96040 CIPRINOL 100 mg/10 ml 100 mg 5X10ML/INF

J01MA02 100 mg/50 ml 59829 CIPRINOL INF 1X50ML/100 mg

59830 CIPRINOL J01MA02 200 mg/100 ml 1X100ML INF/200 mg

86636 J01MA02 CIPROBAY 100 INF 5X50ML/100 mg

86637 J01MA02 CIPROBAY INF 5X100ML 200/200 mg



J01MA03 ABAKTAL 94155 INJ 10X5ML/400 mg

J01MA03 ABAKTAL TBL 94156 OBD 10X400MG



J01XA01 92289 EDICIN 0.5 GM INJ SIC 1X500MG

J01XA01 1GM EDICIN 92290 INJ SIC 1X1GM

J01XA01 01619 VANCOCIN CP 500 mg INJECTION, SIC 1X500MG

05114 TARGOCID INJECTION, 200 mg of J01XA02 SIC 1X200MG + SOL

J01XA02 05113 TARGOCID INJECTION, SIC 1X400MG 400 mg + SOL



J02AA01 44141 ABELCET INF 10X10ML/50 mg

44148 J02AA01 10X10ML/INF ABELCET 50 mg

44142 J02AA01 10X20ML/INF ABELCET 100 mg

J02AA01 44149 ABELCET INF 10X20ML/100 mg

32144 AMPHOCIL 100 INF J02AA01 PLV SOL 10X100MG

32142 AMPHOCIL 50 mg J01AA01 INF PLV SOL 10X50MG

J02AA01 SQUIBB 57548 AMPHOTERICIN B INJ SIC 1X50MG



58431 DIFLAZON 1X100ML J02AC01 INF/200 mg

J02AC01 64946 DIFLUCAN Iv INF 1X100ML 2 mg/ML

J02AC01 46979 FLUCONAZOL-SLOVAKOFARMA for INF INF 1X100ML/200 mg

66036 J02AC01 MYCOMAX 100 CPS 28X100MG

65989 INF INF J02AC01 MYCOMAX 1X100ML/200 mg

59872 MYCOSYST INF J02AC01 10X100ML 2 mg/ML

J02AC01 59871 MYCOSYST INF 1X100ML 2 mg/ML



J02AC02 58872 SPORANOX POR CPS DUR28X100MG



J05AB01 KUMAR 250 93260 INF SIC 10X250MG

53610 XOROX J05AB01 400 mg TBL 60X400MG

J05AB01 53611 800 mg TBL XOROX 35X800MG

J05AB01 64953 ZOVIRAX for INJECTION, 250 mg of SIC 5X250MG

J05AB01 64952 ZOVIRAX 500 mg INJECTION, SIC 5X500MG



02064 CYMEVENE INF J05AB06 SIC 1X500MG

59653 CYMEVENE J05AB06 250 mg POR CPS DUR 84X250MG

J05AB11 30236 VALTREX 500 mg TBL OBD 42X500MG



J05AD01 24 mg/ML 62698 FOSCAVIR INF 1X250ML



J05AE01 55688 INVIRASE CPS 270X200MG

J05AE01 59463 FORTOVASE 200 mg CPS 360X400MG



J05AE02 44124 CRIXIVAN 200 CPS 360X200MG

J05AE02 44126 CRIXIVAN 400 CPS 180X400MG



J05AE03 2X84 = 57784 NORVIR CPS 168X100MG



86100 J05AF01 RETROVIR INF CNC 5X20ML/200 mg

J05AF01 58729 RETROVIR 100 CPS 100X100MG

J05AF01 58728 RETROVIR 250 CPS 40X250MG



J05AF02 57422 VIDEX 100 mg CTB 60X100MG

57423 VIDEX 200 mg J05AF02 60X150MG CTB



J05AF03 66733 HIVID 0.375 MG TBL 100 x 0.375 MG. OBD-B

J05AF03 66734 HIVID 0.75 MG TBL OBD 100 x 0.75 MG-B



J05AF04 53209 ZERIT 40 mg CPS 56X40MG



J05af05 47158 EPIVIR TBL OBD 60X150MG

J05af05 02086 ZEFFIX 100 mg TBL OBD 84X100MG



J05AF06 58396 ZIAGEN TBL OBD 60X300MG



J05AF30 TBL 60 57852 COMBIVIR OBD (blister)

J05AF30 TBL 60 59221 COMBIVIR OBD (the.)



J05AG01 TBL 60X200MG VIRAMUNE 57777



J05AG03 200 mg STOCRIN 59948 CPS 90X200MG



B03XA01 85530 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.2 ML/3KU

B03XA01 85531 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.4 ML/purchase

B03XA01 57340 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.5 ML/5KU

B03XA01 57341 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.6 ML/6KU

B03XA01 57342 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.7 ML/7KU

B03XA01 57343 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.8 ML/8KU

B03XA01 57344 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.6 ML/9KU

B03XA01 85532 EPREX 1000 IU/0.1 ML INJ SOL 6X1ML/10KU

B03XA01 85528 EPREX 200 IU/0.1 ML INJ SOL 6 x 0.5 ML/1KU

B03XA01 93579 EPREX 200 IU/0.1 ML SOL 6X1ML/2KU INJ

B03XA01 02267 EPREX 40 000 INJ SOL 1X1ML/40KU

B03XA01 85529 EPREX 400 IU/0.1 ML INJ SOL 6 x 0.5 ML/2KU

B03XA01 58451 NEORECORMON 10 000 IU INJ SOL 6 x 0.6 ML/10KU

B03XA01 64816 NEORECORMON 1000 IU INJ SOL 6 x 0.2 ML/1KU

B03XA01 58453 NEORECORMON 20 000 IU INJ SOL 6 x 0.6 ML/20KU

B03XA01 64812 NEORECORMON 2000 IU INJ SOL 6 x 0.2 ML/2KU

B03XA01 64818 NEORECORMON 3000 IU INJ SOL 6 x 0.2 ML/3KU

B03XA01 06221 NEORECORMON for INJ SOL 6 x 0.2 ML/purchase

B03XA01 64814 NEORECORMON 500 IU INJ SOL 6 x 0.2 ML/500UT

B03XA01 58449 NEORECORMON 5000 IU INJ SOL 6 x 0.2 ML/5KU

B03XA01 58686 NEORECORMON MULTIDOSE 100000 INJ PSO LQF 1X100KU + S

B03XA01 58685 NEORECORMON MULTIDOSE 50000 INJ PSO LQF 1X50KU + SAT

B03XA01 58688 NEORECORMON for RECO-PEN INJ 10000 PSO LQF 3X10KU + S

B03XA01 58744 NEORECORMON for RECO-PEN INJ 20000 PSO LQF3X20KU + SAT

-------------------------------------------------------------------------



Č. 7



List of inpatient health care facility-center for treatment of burns

+--+----------+------------------------+------------+-------------------------+

| # | CORPORATE ID | The name of the post operative care | Head Office | The workplace |

| | | equipment | | |

+--+----------+------------------------+------------+-------------------------+

| # 1 | 00064173 | University Hospital | Prague 10 | The clinic |

| | | Královské Vinohrady | | Burns medicine |

+--+----------+------------------------+------------+-------------------------+

| 2 | 00843989 | University Hospital | Ostrava-| Burns |

| | | with health center | Poruba | Center |

+--+----------+------------------------+------------+-------------------------+

| # 3 | 65269705 | University Hospital Brno | Brno | Centre (clinic) |

| | | | | Burns and |

| | | | | Reconstructive surgery |

+--+----------+------------------------+------------+-------------------------+



Č. 8



List of inpatient health care facility-center for the treatment of cystic

Fibrosis

+--+----------+--------------------------+----------+------------------------+

| # | CORPORATE ID | The name of the post operative care | Head Office | The workplace |

+--+----------+--------------------------+----------+------------------------+

| # 1 | 00064203 | University Hospital | Prague 5 | 2. Department of Pediatrics, thorn |

| | | in motol | | |

+--+----------+--------------------------+----------+------------------------+

| 2 | 65269705 | University Hospital Brno | Brno | Infectious diseases clinic of the DFN, |

| | | | | pulmonary clinic |

+--+----------+--------------------------+----------+------------------------+

| # 3 | 00179906 | Faculty hospital Hradec | Hradec | The Department of Pediatrics |

| | | Kings | Kings | |

+--+----------+--------------------------+----------+------------------------+

| 4 | 00669806 | Faculty hospital Pilsen | Pilsen | The Department of Pediatrics |

+--+----------+--------------------------+----------+------------------------+

| 5. | 00098892 | University Hospital | Olomouc | The Department of Pediatrics |

| | | Olomouc | | and Department of THORN |

+--+----------+--------------------------+----------+------------------------+



Č. 9



List of medicinal products for the treatment of cystic fibrosis

----------------------------------------------------------------------------

ATC code Name the add-in name

----------------------------------------------------------------------------

J01CR05 TAZOCIN 2.25 GM 84783 INJ SIC 1 x 2.25 GM

J01CR05 TAZOCIN 4.5 GM 84784 INJ SIC 1 x 3.5 GM



J01DA 94756 2GM SULPERAZON IM/IV INJ SIC 1 (1GM + 1GM)



J01DA11 76353 1 g INJ SIC 1X1GM FORTUM

J01DA11 76354 FORTUM 2 g INJ SIC 1X2GM

J01DA11 76355 FORTUM 500 mg INJECTION, SIC 1X500MG



87199 J01DA24 MAXIPIME 1 GM INJ SIC 1X1GM

87200 J01DA24 MAXIPIME 2 GM INJ SIC 1X2GM

87198 J01DA24 SIC 1X500MG MAXIPIME INJ 500 mg



J01DH02 83487 MERONEM INJ SIC 10X500MG



J01GB06 11785 AMIKIN INJECTION 1 G 1X4ML/1GM

AMIKIN INJECTION 100 mg 03951 J01GB06 1X2ML/100 mg

AMIKIN INJECTION 500 mg J01GB06 03952 1X2ML/500 mg



90485 J01GB07 NETROMYCINE 200 mg/2 ml 1X2ML/INJ 200 mg

83736 J01GB07 NETROMYCINE 400 mg/2 ml INJECTION 1X2ML/400 mg



J01MA02 53715 CIFLOXINAL TBL OBD 200X250MG

J01MA02 CIPHIN for INFUSION 53922.200 mg/100 ml 1X100ML INF/200 mg

53921 J01MA02 CIPHIN 100 mg/50 ml for INFUSIONE INF 1X50ML/100 mg

J01MA02 56830 CIPLOX INF 1X100ML (plastic)

44989 J01MA02 CIPLOX 250 TBL OBD 50X250MG

J01MA02 44986 CIPLOX 500 TBL OBD 50X500MG

J01MA02 96040 CIPRINOL 100 mg/10 ml 100 mg 5X10ML/INF

J01MA02 100 mg/50 ml 59829 CIPRINOL INF 1X50ML/100 mg

59830 CIPRINOL J01MA02 200 mg/100 ml 1X100ML INF/200 mg



J01XB01 COLIMYCINE SIC 50X1MU 61178 INJ



J02AA01 44141 ABELCET INF 10X10ML/50 mg

44148 J02AA01 10X10ML/INF ABELCET 50 mg


44142 J02AA01 10X20ML/INF ABELCET 100 mg

J02AA01 44149 ABELCET INF 10X20ML/100 mg



58431 DIFLAZON 1X100ML J02AC01 INF/200 mg

J02AC01 DIFLAZON 100 CPS 59787 28X100MG

J02AC01 64946 DIFLUCAN Iv INF 1X100ML 2 mg/ML

J02AC01 46979 FLUCONAZOL-SLOVAKOFARMA for INF INF 1X100ML/200 mg

66036 J02AC01 MYCOMAX 100 CPS 28X100MG

65989 INF INF J02AC01 MYCOMAX 1X100ML/200 mg

59872 MYCOSYST INF J02AC01 10X100ML 2 mg/ML

J02AC01 59874 MYCOSYST CPS 100 mg 28X100MG

J02AC02 58872 SPORANOX POR CPS DUR28X100MG



R05CB13 77521 PULMOZYME INH SOL 6 x 2.5 ML



A09AA02 44015 KREON 10000 CPS 20

A09AA02 68989 KREON 25000 50 CPS

V06DB 59109 FRESUBIN 750 MCT SOL 12X500ML

V06DB POR SUS 56244 INKODIET STANDARD 12X500ML

V06DB INKOPEPTID POR SUS 56246 SONDE 12X500ML

NUTRISON ENERGY 45529 V06DB SOL 1X1000ML (BAG)

NUTRISON MULTI FIBRE 45793 V06DB SOL 1X1000ML (BAG)

V06DB 61454 NUTRISON POWDER PLV 1X430GM

NUTRISON STANDARD 53375 V06DB SOL 1X1000ML (BAG)

49470 SUPPORTAN NEUTRAL V06DB SOL 12X500ML

V06DB SURVIMED OPD 57357 NEUTRAL SOL 12X500ML

V06DC 1X400GM FANTOMALT PLV 75153

----------------------------------------------------------------------------



Č. 10



List of inpatient health care facility-workplaces for the treatment

oncologically ill children

-----------------------------------------------------------------------------

No ID Name of post operative care Gynecology

device

-----------------------------------------------------------------------------

1.00064203 University Hospital Prague 5 children's clinic

in motol

-----------------------------------------------------------------------------

2.65269705 the Faculty hospital Brno Brno Department of children's Oncology

-----------------------------------------------------------------------------



Č. 11



List of medicinal products for the treatment of sick children with cancer "

---------------------------------------------------------------------------

ATC code Name the add-in name

---------------------------------------------------------------------------

B03XA01 85530 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.2 ML/3KU

B03XA01 85531 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.4 ML/purchase

B03XA01 57340 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.5 ML/5KU

B03XA01 57341 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.6 ML/6KU

B03XA01 57342 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.7 ML/7KU

B03XA01 57343 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.8 ML/8KU

B03XA01 57344 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.6 ML/9KU

B03XA01 85532 EPREX 1000 IU/0.1 ML INJ SOL 6X1ML/10KU

B03XA01 85528 EPREX 200 IU/0.1 ML INJ SOL 6 x 0.5 ML/1KU

B03XA01 93579 EPREX 200 IU/0.1 ML SOL 6X1ML/2KU INJ

B03XA01 02267 EPREX 40 000 INJ SOL 1X1ML/40KU

B03XA01 85529 EPREX 400 IU/0.1 ML INJ SOL 6 x 0.5 ML/2KU

B03XA01 58451 NEORECORMON 10 000 IU INJ SOL 6 x 0.6 ML/10KU

B03XA01 64816 NEORECORMON 1000 IU INJ SOL 6 x 0.2 ML/1KU

B03XA01 58453 NEORECORMON 20 000 IU INJ SOL 6 x 0.6 ML/20KU

B03XA01 64812 NEORECORMON 2000 IU INJ SOL 6 x 0.2 ML/2KU

B03XA01 64818 NEORECORMON 3000 IU INJ SOL 6 x 0.2 ML/3KU

B03XA01 06221 NEORECORMON for INJ SOL 6 x 0.2 ML/purchase

B03XA01 64814 NEORECORMON 500 IU INJ SOL 6 x 0.2 ML/500UT

B03XA01 58449 NEORECORMON 5000 IU INJ SOL 6 x 0.2 ML/5KU

B03XA01 58686 NEORECORMON MULTIDOSE 100000 INJ PSO LQF 1X100KU + S

B03XA01 58685 NEORECORMON MULTIDOSE 50000 INJ PSO LQF 1X50KU + SAT

B03XA01 58688 NEORECORMON for RECO-PEN INJ 10000 PSO LQF 3X10KU + S

B03XA01 58744 NEORECORMON for RECO-PEN INJ 20000 PSO LQF 3X20KU + SAT

J02AA01 44141 ABELCET INF 10X10ML/50 mg

44148 J02AA01 10X10ML/INF ABELCET 50 mg

44142 J02AA01 10X20ML/INF ABELCET 100 mg

J02AA01 44149 ABELCET INF 10X20ML/100 mg

32144 AMPHOCIL 100 INF J02AA01 PLV SOL 10X100MG

32142 AMPHOCIL 50 mg J02AA01 INF PLV SOL 10X50MG

J02AA01 SQUIBB 57548 AMPHOTERICIN B INJ SIC 1X50MG

---------------------------------------------------------------------------



Č. 12



List of inpatient health care facility-kardiocenter carrying out

the performances of invasive and interventional cardiology according to § 2 paragraph 7, subparagraphs (l))

and (m)) of this Ordinance

------------------------------------------------------------------------------

no name of the socket device ID the registered office

------------------------------------------------------------------------------

1.00064165 General faculty hospital in Prague 2



2.00023001 Institute of clinical and experimental Prague 4

medicine



3.00064203 teaching hospital in motol Prague 5



4.00023884 Na Homolce hospital Prague 5



5.61383082 central military hospital Prague 6



6.49679236 Cardiology na s.r.o. Prague 8



7.00064173 of the Faculty hospital Královské Vinohrady Prague 10



8.00072711 Hospital České Budějovice České Budějovice



9.00669806 University Hospital Plzeň Plzeň



10.00179906 University Hospital Hradec Králové Hradec Králové



11 65269705 University Hospital Brno Brno



12.00159816 University Hospital. Anny In Brno



13.00209775 cardiovascular Center and Brno

transplant surgery



14.00843989 teaching hospital with policlinic in Ostrava-Poruba

Ostrava-Poruba



15.00635162 municipal hospital Ostrava-Moravská Ostrava Fifejdy



16.48401129 Hospital Archet s.r.o. Třinec



17.00098892 University Hospital Olomouc, Olomouc



18.00089915 Bata hospital Zlín

-----------------------------------------------------------------------------



Č. 13



List of inpatient health facilities implementing Endovascular

treatment of aneurysms and arterial dissection, stenosis of cerebral arteries, brain

arteriovenous shunts and malformations

----------------------------------------------------------------------------

no name of the socket device ID the registered office

----------------------------------------------------------------------------

1.00064165 General faculty hospital in Prague 2



2.00023001 Institute of clinical and experimental Prague 4

medicine



3.00023884 Na Homolce hospital Prague 5



4.61383082 central military hospital Prague 6



5.00064173 of the Faculty hospital Královské Vinohrady Prague 10



6.00669806 University Hospital Plzeň Plzeň



7.00179906 University Hospital Hradec Králové Hradec Králové



8.65269705 the Faculty hospital Brno, Brno



9.00843989 teaching hospital with policlinic in Ostrava-Poruba

Ostrava-Poruba



10.00098892 University Hospital Olomouc, Olomouc



11.00159816 University Hospital. Anny In Brno



12.00064211 teaching hospital Na Prague 8



13.00064203 teaching hospital in motol Prague 5



14.00072711 Hospital České Budějovice České Budějovice



15.00673544 Masaryk hospital with policlinic, Ústí nad Labem



16.829951 Hospital Liberec Liberec

----------------------------------------------------------------------------



Č. 14



List of inpatient health care facility-workplaces for surgical treatment

stress incontinence

----------------------------------------------------------------------------

no name of the socket device ID the registered office

----------------------------------------------------------------------------

1.00064211 teaching hospital Na Prague 8



2. the 00023698 Institute for the care of mother and child, Prague 4



3.00064165 General faculty hospital in Prague 2



4.00843989 teaching hospital with policlinic in Ostrava-Poruba

Ostrava-Poruba



5.00844896 hospital with policlinic, Havířov-Město



6.48512478 Hospital of Merciful brethren Brno



7.65269705 the Faculty hospital Brno, Brno



8.60726636 Hospital Atlas, a.s. Zlín



9.00089915 Bata hospital Zlín



10.00875384 Hospital Kladno Kladno



11.49813692 first private surgical Centre Hradec Kralove

SANUS



12.00072711 Hospital České Budějovice České Budějovice



13.00829838 Hospital in Jablonec nad Nisou



14.00669806 University Hospital Plzeň Plzeň



15.00098892 University Hospital Olomouc, Olomouc



16.00390780 Hospital Břeclav Břeclav

----------------------------------------------------------------------------



Annex 15



A list of the medicinal products containing an active substance erythropoietin for the treatment of

germinal tumors, ovarian cancer, lung cancer, cancer

breast cancer and cancers of the cervix, in the orofacial area, malignant

tumors of the placenta, multiple myeloma and chronic lymphocytic leukemia

------------------------------------------------------------------------------

ATC code Name the add-in name

------------------------------------------------------------------------------

B03XA01 85530 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.2 ML/3KU

B03XA01 85531 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.4 ML/purchase

B03XA01 57340 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.5 ML/5KU

B03XA01 57341 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.6 ML/6KU

B03XA01 57342 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.7 ML/7KU

B03XA01 57343 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.8 ML/8KU


B03XA01 57344 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.6 ML/9KU

B03XA01 85532 EPREX 1000 IU/0.1 ML INJ SOL 6X1ML/10KU

B03XA01 85528 EPREX 200 IU/0.1 ML INJ SOL 6 x 0.5 ML/1KU

B03XA01 93579 EPREX 200 IU/0.1 ML SOL 6X1ML/2KU INJ

B03XA01 02267 EPREX 40 000 INJ SOL 1X1ML/40KU

B03XA01 85529 EPREX 400 IU/0.1 ML INJ SOL 6 x 0.5 ML/2KU

B03XA01 58451 NEORECORMON 10 000 IU INJ SOL 6 x 0.6 ML/10KU

B03XA01 64816 NEORECORMON 1000 IU INJ SOL 6 x 0.2 ML/1KU

B03XA01 58453 NEORECORMON 20 000 IU INJ SOL 6 x 0.6 ML/20KU

B03XA01 64812 NEORECORMON 2000 IU INJ SOL 6 x 0.2 ML/2KU

B03XA01 64818 NEORECORMON 3000 IU INJ SOL 6 x 0.2 ML/3KU

B03XA01 06221 NEORECORMON for INJ SOL 6 x 0.2 ML/purchase

B03XA01 64814 NEORECORMON 500 IU INJ SOL 6 x 0.2 ML/500UT

B03XA01 58449 NEORECORMON 5000 IU INJ SOL 6 x 0.2 ML/5KU

B03XA01 58686 NEORECORMON MULTIDOSE 100000 INJ PSO LQF 1X100KU + S

B03XA01 58685 NEORECORMON MULTIDOSE 50000 INJ PSO LQF 1X50KU + SAT

B03XA01 58688 NEORECORMON for RECO-PEN INJ 10000 PSO LQF 3X10KU + S

B03XA01 58744 NEORECORMON for RECO-PEN INJ 20000 PSO LQF 3X20KU + SAT

------------------------------------------------------------------------------



Č. 16



List of selected inpatient facility for the treatment of multiple myeloma-the center

Myeloma and chronic lymphocytic leukemia

------------------------------------------------------------------------------

No INFRARED devices have a specific name, Gynecology

------------------------------------------------------------------------------

1.00064165 Autonomous University Prague 2 internal clinic

Hospital



2.00023736 Institute of Hematology and blood Prague 2 Hematology

transfusion medicine



3.00064173 University Hospital Prague 10 Hematology Department

Královské Vinohrady



4.0019906 University Hospital Hradec Králové Hradec Hematology Department

The Kings of the



5.00669806 University Hospital Plzeň Plzeň Hematological Department



6.00098892 University Hospital Olomouc, Olomouc, Hematoonkologická clinic



7. The Faculty hospital Brno Brno 65269705 Internal hematoonkologická clinic



8.00064203 teaching hospital Motol Prague Oncology

------------------------------------------------------------------------------



Č. 17



List of selected inpatient facility-center for treatment of germ

cancer, ovarian cancer, lung cancer, breast cancer,

Carcinoma of the cervix cancers in the orofacial area, and malignant tumors

the placenta

------------------------------------------------------------------------------

No INFRARED devices have a specific name, Gynecology

------------------------------------------------------------------------------

1.00064165 Autonomous University Prague 2 internal clinic

Hospital



2.00064190 the University Thomayer Prague 4 Oncology Department

Hospital Prague



3.00064173 University Hospital Prague 10 Oncology Department

Královské Vinohrady



4.0019906 University Hospital Hradec Králové Hradec Oncology Department

The Kings of the



5.00669806 University Hospital Plzeň Plzeň Oncology Department



6.00098892 University Hospital Olomouc, Olomouc Oncology



7.00072711 Hospital České Budějovice Czech Oncological Department

Budějovice



8.00843989 University Hospital Ostrava-Oncology Department with

policlinic Poruba



9.00159816 University Hospital. Brno Department of clinical

Anna and radiation oncology



10.65269705 the Faculty hospital Brno Brno Oncology Department



11.00209805 Brno Masaryk Memorial Cancer Oncology Department

Institute of



12.00064203 Prague 5 Motol University Hospital Oncology Department

adult



13.00064211 University Hospital Prague 8, Department of radiation oncology

Bulovka

------------------------------------------------------------------------------



Č. 18



The procedure to calculate the increase of the remuneration referred to in § 7 para. 1



NUZZ = [(P02/P01-1) x 0.8 x UZZ02]-(UZZ02-UZZ01)



where:



NUZZ = increase in remuneration for a specific medical device 2.

half of 2002



P01 = actual revenue from a selection of premium total after redistribution in 2.

half of 2001 (that is from 7-12. the reallocation including) after deduction of

receipts for claims incurred by the Consolidation Bank, Prague



P02 = actual revenue from a selection of premium total after redistribution in 2.

half of 2002 (that is, from 7 to 12, including redistribution)



UZZ01 = reimbursement for a specific medical device 2. half-year 2001

reported by medical institutions and recognized by the health insurance company to 31.

March 2002, minus the payment for the items in the scope of § 2, para. 7

the Ordinance, effected in the relevant period



UZZ02 = reimbursement for a specific medical device 2. half of 2002

reported by medical institutions and recognized by the health insurance company to 31.

March 2003, minus the payment for the items in the scope of § 2, para. 7

the Ordinance, effected in the relevant period.



The conditions for the calculation:



1. in the case that UZZ02 < UZZ01, then the expression (UZZ02-UZZ01) we set

a value of 0



2. in the case that NUZZ < 0, then the increase in remuneration for a specific medical facility for 2 half-year 2002 does not 3. in the case that UZZ02/UZZ01-1 > = (P01/-P02 1) x 0.8, then

the increase of the remuneration for a specific medical device 2. half of 2002

does not perform



4. in the event that in the 2. half of 2002 there has been an increase in the contract

the capacity of medical device compared with 2. half of 2001, the volume of this

care is not included in the UZZ02 item in the calculation under section 7, Appendix No. 18

the Decree.



XIII. 19



Angiotensin receptor glycoprotein IIb/IIIa

+----------+----------+----------------------+--------------------+

| ATC | Code | The name | The add-in name |

+----------+----------+----------------------+--------------------+

| B01AC13 | 56610 | REOPRO | INJ 1X5ML/10 mg |

+----------+----------+----------------------+--------------------+

| B01AC16 | 46802 | INTEGRILIN 0.75 MG/ML | INF 1X100ML/75 mg |

+----------+----------+----------------------+--------------------+

| B01AC16 | 46800 | INTEGRILIN 2 mg/ML | INJ 1X10ML/20 mg |

+----------+----------+----------------------+--------------------+



1) Decree No. 134/1998 Coll. issuing the list of medical procedures

with point values, as amended.



2) Article. (II) Act No. 459/2000 Coll., amending Act No. 48/1997 Coll.

on public health insurance and amending and supplementing certain

related laws, as amended.



Annex 1, point B) 1. Government Regulation No. 487/2000 Coll. laying

provides point values, and the amount of the reimbursement of health care covered by the public

health insurance for 1. half of 2001.



3) Article. (II) Act No. 459/2000 Coll.



§ 2 (2). 7 (b). e) Government Regulation No. 487/2000 Coll.



4) Article. (II) Act No. 459/2000 Coll.



§ 2 (2). 7 (b). I) Government Regulation No. 487/2000 Coll.



5) Article. (II) Act No. 459/2000 Coll.



Appendix No. 2 item B) 1. Government Regulation No. 487/2000 Coll.



6) Article. (II) Act No. 459/2000 Coll.



section 4, paragraph 4. 2 Government Regulation No. 487/2000 Coll.



7) Article. (II) Act No. 459/2000 Coll.



§ 5 para. 2 Government Regulation No. 487/2000 Coll.



8) § 40 paragraph 2. 2 of the Act 48/1997 Coll. No.



9) Article. (II) Act No. 459/2000 Coll.



section 6 (a). (b)) Government Regulation No. 487/2000 Coll.

Related Laws